IL6ST and head and neck squamous cell carcinoma: Specifically, within the subgroup characterized by both high TANIS and high s-gp130 values, 7 out of 8 patients died of HNSCC, contrasting with 11 out of 25 patients in the extended TANIS stage and low s-gp130 subgroup (p < 0.004) (Figure 7B).